Baxter International Inc. announced that the company has submitted a biologics license application (BLA) to the FDA for the approval...
Results from the HydroEye clinical trial of HydroEye (DHA, EPA and GLA), from ScienceBased Health, showed that the omega fatty...
Gilead Sciences, Inc. presented new data reinforcing the efficacy, safety, and tolerability profile of lenacapavir, including patient-reported outcomes (PRO) from the Phase II/III CAPELLA trial
Omthera Pharmaceuticals has reported positive data showing that its prescription-grade omega-3 fatty acid candidate, Epanova, has better bioavailability than Lovaza...
Results of the DHA Oxford Learning and Behaviour (DOLAB) study suggests that taking lifes DHA (docosahexaenoic acid), an omega-3 fatty...
Fuzeon is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected patients who have received treatment with and failed on regimens containing at least one medicinal product from each of the following antiretroviral classes: protease inhibitors, non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors, or who have intolerance to previous antiretroviral regimens (see section 5.1). In deciding on a new regimen for patients who have failed an antiretroviral regimen, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different medicinal products. Where available, resistance testing may be appropriate (see sections 4.4 and 5.1).
A new study has uncovered a mechanism by which omega-3 fatty acids can benefit Cardiovascular health. Prof. Heinemann (Jena University),...
Trial data published in Neurology from 1500 dementia-free participants who underwent MRI scanning suggested that diet levels in omega-3 fatty...
BD (Becton, Dickinson and Company) released findings from a survey conducted by The Harris Poll, between Nov. 14-16, 2022, among 872 U.S. women ages 18 to 64 years old, that indicate a significant gap in women's knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.